BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, November 3, 2024
Home
»
Topics
» Immuno-oncology, BioWorld Science
Immuno-oncology, BioWorld Science
RSS
Positive clinical results reported for MDX-22 in AML patients
Dec. 12, 1996
No Comments
Positive IDEC-C2B8 phase III trial results announced
Dec. 11, 1996
No Comments
Medarex bispecific antibody enters phase II in colon cancer patients
Dec. 9, 1996
No Comments
Sandoz claims MAbs against Lewis group antigens for therapeutic use
Nov. 25, 1996
No Comments
IDEC to present final pivotal data on IDEC-C2B8
Nov. 22, 1996
No Comments
NCI sponsors clinical trials with Therion's prostate cancer vaccine
Nov. 22, 1996
No Comments
First filing for Imutec's Virulizin
Nov. 21, 1996
No Comments
Final phase II data presented for Biomira's therapeutic cancer vaccine
Nov. 15, 1996
No Comments
Ovarian cancer vaccine enters pivotal trials in Europe
Nov. 8, 1996
No Comments
Apoptosis-inducing MAb from Chugai
Nov. 8, 1996
No Comments
Previous
1
2
…
925
926
927
928
929
930
931
932
933
934
935
Next
RSS